NCT07502911

Brief Summary

The aim of this study is to examine the effect of a gender-specific heart health protection awareness program, incorporating video-supported reminder messages, on knowledge, attitudes, practices (KAP) regarding cardiovascular diseases and health literacy among adult women aged 20 to 64 with no prior diagnosis of cardiovascular disease. The centers where the study is conducted will be divided into intervention (n=4) and control (n=5) groups using cluster randomization. While the intervention group receives a heart health awareness program consisting of three sessions in total, including education, risk factor screening, and individual counseling over a period of three weeks, the control group will receive standard of care. Data will be collected at the beginning of the first session and after the completion of the final session.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
207

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 25, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 31, 2026

Completed
6 days until next milestone

Study Start

First participant enrolled

April 6, 2026

Completed
14 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 20, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 20, 2026

Completed
Last Updated

March 31, 2026

Status Verified

March 1, 2026

Enrollment Period

14 days

First QC Date

March 25, 2026

Last Update Submit

March 25, 2026

Conditions

Keywords

Cardiovascular diseaseswomen's healthhealth literacy

Outcome Measures

Primary Outcomes (4)

  • Change in knowledge sub-dimension scores of the Cardiovascular Disease KAP Scale from baseline to post-intervention.

    The knowledge sub-dimension of the scale consists of 12 items designed to assess individuals' knowledge levels regarding cardiovascular disease risk factors and symptoms. Each item is scored as 0, 1, or 2, with total sub-dimension scores ranging from a minimum of 0 to a maximum of 24.

    Baseline (Week 0) and at the end of the 3-week intervention period

  • Change in attitude sub-dimension scores of the Cardiovascular Disease KAP Scale from baseline to post-intervention

    The attitude sub-dimension of the scale consists of 10 items designed to assess individuals' attitudes toward cardiovascular diseases. It utilizes a 5-point Likert-type scale, with total scores ranging from a minimum of 10 to a maximum of 50.

    Baseline (Week 0) and at the end of the 3-week intervention period

  • Change in physical activity behaviors sub-dimension scores of the Cardiovascular Disease KAP Scale from baseline to post-intervention

    The physical activity practices sub-dimension of the scale consists of two items assessing individuals' practices regarding cardiovascular disease risk factors. These items are scored using a 3-point rating scale (0-2).

    Baseline (Week 0) and at the end of the 3-week intervention period

  • Change in diet and smoking behavior behaviors sub-dimension scores of the Cardiovascular Disease KAP Scale from baseline to post-intervention

    The diet and smoking practices sub-dimension of the scale consists of five items assessing individuals' practices regarding cardiovascular disease risk factors. These items are scored using a 3-point rating scale (0-2).

    Baseline (Week 0) and at the end of the 3-week intervention period

Secondary Outcomes (1)

  • Change in Health Literacy Scale-Short Form scores from baseline to post-intervention

    Baseline (Week 0) and at the end of the 3-week intervention period

Study Arms (2)

Control Group

NO INTERVENTION

Participants in the control group will not receive any intervention during the study and will continue to receive standard services. Data from this group will be collected concurrently with the intervention group at baseline and at the end of the 3rd week. For ethical reasons, following the collection of post-test data, educational brochures will be provided, and a screening session along with brief individual counseling will be conducted for the control group participants.

Intervention Group

EXPERIMENTAL

Participants will receive a heart health awareness program including education on cardiovascular disease prevention, risk factor screening, and brief individual counseling. Pre-test measurements will be taken before the intervention, and post-tests will be administered upon completion of the final session.

Behavioral: Heart Health Awareness Program

Interventions

Intervention group participants will receive a 3-week program focused on cardiovascular diseases prevention, consisting of 45-minute weekly sessions. The first two sessions are educational sessions involving visual presentations, Q\&A, and discussions, with informative brochures provided. To reinforce learning, six reminder video messages will be sent via WhatsApp every two days post-educational sessions. The final session includes a CVD risk screening (height, weight, BMI, waist circumference, blood pressure, and blood glucose) followed by brief individual counseling. Interventions will be conducted simultaneously across all sites by specially trained nurses. Pre-test measurements will be taken before the intervention, and post-tests will be administered upon completion of the final session.

Intervention Group

Eligibility Criteria

Age20 Years - 64 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Being female,
  • Aged between 20 and 64 years (inclusive),
  • Being literate,
  • Regularly attending any course at the Family Center,
  • Active user of the WhatsApp application.

You may not qualify if:

  • Being an immigrant with a Turkish language barrier (unable to communicate in Turkish),
  • Being pregnant,
  • Being in the postpartum period,
  • Having a prior diagnosis of any cardiovascular disease,
  • Having a prior diagnosis of any type of cancer.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Lokman Hekim Universty

Ankara, 06510, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Cardiovascular Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The study is designed as single-blind at the participant level. The data collection process will be conducted by independent individuals outside of the research team who are unaware of the participants' group assignments. However, the Principal Investigator, who will analyze and evaluate the data, is not blinded as they are aware of the group assignments.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: This is a cluster randomized study. Randomization was performed at the center level rather than at the individual level.
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

March 25, 2026

First Posted

March 31, 2026

Study Start

April 6, 2026

Primary Completion

April 20, 2026

Study Completion

April 20, 2026

Last Updated

March 31, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Individual participant data will not be broadly shared to ensure participant confidentiality.

Locations